Zbigniew Żuber - Concepedia

Author

Zbigniew Żuber

Also Known As

A. Baheti, Hermine I. Brunner, K. Minden, N Ruperto, Z Zuber, Z Żuber, Z. Zuber, Z. Żuber, Zbigniew M Żuber, Zbigniew M. Żuber

133

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Istituto Giannina Gaslini Uniwersytecki Szpital Dziecięcy Children's Memorial Health Institute University of Genoa University of Gdańsk

ZŻ

About

Zbigniew Żuber is an author at Istituto Giannina Gaslini specializing in medicine, pathology, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	174
2	Immunology	1	1	21
3	Molecular Medicine	1	1	21
4	Neurology	1	1	17
5	Obstetrics	1	1	13

Zbigniew Żuber

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis Fabrizio De Benedetti, Hermine I. Brunner, Nicolino Ruperto, New England Journal of Medicine	2012	840
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber, Annals of the Rheumatic Diseases	2014	296
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study Gerd Horneff, Rubén Burgos‐Vargas, Tamás Constantin, Annals of the Rheumatic Diseases	2013	129
Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3‐year follow‐up A Szymanska, Agnieszka Jurecka, Zbigniew Żuber, Acta Paediatrica	2011	69
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial Hermine I. Brunner, Ivan Foeldvari, Nuray Aktay Ayaz, Annals of the Rheumatic Diseases	2022	64
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial Athimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, The Lancet RheumatologyJuvenile Idiopathic ArthritisPediatricsOsteoarthritisSafety Trial	2023	64
Plantar Versus Dorsal Incision in the Treatment of Primary Intermetatarsal Morton's Neuroma Christian Åkermark, Hans Crone, Tönu Saartok, Foot & Ankle International	2008	48
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial Ivan Foeldvari, Tamás Constantin, Jelena Vojinović, Arthritis Research & Therapy	2019	39
A prospective 2-year follow-up study of plantar incisions in the treatment of primary intermetatarsal neuromas (Morton's neuroma) Christian Åkermark, Tönu Saartok, Zbigniew Żuber Foot and Ankle Surgery Neuro-oncologyPlantar IncisionsMedicinePrimary Intermetatarsal NeuromasSurgery	2008	37
Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber, Arthritis & Rheumatology	2020	35

Page 1